Technical Analysis for PCRX - Pacira Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 29.29 -0.41% -0.12
PCRX closed down 0.41 percent on Monday, March 18, 2024, on 64 percent of normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Pocket Pivot Bullish Swing Setup -0.41%
Bollinger Band Squeeze Range Contraction -0.41%
Fell Below 20 DMA Bearish 0.10%
Bollinger Band Squeeze Range Contraction 0.10%
Multiple of Ten Bearish Other 0.10%
Down 3 Days in a Row Weakness 0.10%
Down 4 Days in a Row Weakness 0.10%
20 DMA Support Bullish -3.30%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 18 hours ago
Fell Below Previous Day's Low about 20 hours ago
Down 2 % about 20 hours ago
Down 1% about 20 hours ago
Down 1% 4 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pacira Pharmaceuticals, Inc. Description

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers worldwide. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company markets EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic, indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase II clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate that is in preclinical trials for the treatment of rheumatoid arthritis and oncology, as well as Bupivacaine Liposome Injectable Suspension for veterinary postsurgical analgesia. Pacira Pharmaceuticals, Inc. has a development and commercialization agreement, and related supply agreement with Aratana Therapeutics, Inc. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Immune System Pain Surgery Pharmaceutical Products Lymphoma Pharmacology Rheumatoid Arthritis Drug Delivery Suspension Acute Pain Nerve Bupivacaine Drug Delivery Technology Meningitis Piperidines Liposome Local Anesthetic Surgical Site Methotrexate

Is PCRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.6
52 Week Low 25.93
Average Volume 516,323
200-Day Moving Average 32.86
50-Day Moving Average 30.88
20-Day Moving Average 29.91
10-Day Moving Average 30.14
Average True Range 1.05
RSI (14) 43.50
ADX 21.25
+DI 13.35
-DI 25.41
Chandelier Exit (Long, 3 ATRs) 28.31
Chandelier Exit (Short, 3 ATRs) 31.05
Upper Bollinger Bands 31.15
Lower Bollinger Band 28.68
Percent B (%b) 0.25
BandWidth 8.27
MACD Line -0.18
MACD Signal Line -0.17
MACD Histogram -0.0136
Fundamentals Value
Market Cap 1.36 Billion
Num Shares 46.4 Million
EPS 0.15
Price-to-Earnings (P/E) Ratio 195.27
Price-to-Sales 2.01
Price-to-Book 1.61
PEG Ratio -3.83
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.67
Resistance 3 (R3) 30.62 30.12 30.44
Resistance 2 (R2) 30.12 29.77 30.14 30.36
Resistance 1 (R1) 29.71 29.55 29.46 29.75 30.28
Pivot Point 29.20 29.20 29.08 29.23 29.20
Support 1 (S1) 28.79 28.85 28.54 28.83 28.30
Support 2 (S2) 28.29 28.64 28.31 28.22
Support 3 (S3) 27.87 28.29 28.14
Support 4 (S4) 27.91